Marshall Wace, LLP Maravai Lifesciences Holdings, Inc. Transaction History

Marshall Wace, LLP

$81.7 Billion
Q2 2025

A detailed history of Marshall Wace, LLP transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 322,110 shares of MRVI stock, worth $866,475. This represents 0.0% of its overall portfolio holdings.

Number of Shares

322,110

Previous 394,012 18.25%

Holding current value

$866,475

Previous $870,000 10.8%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$1.72 - $2.47 $123,671 - $177,597	-71,902 Reduced 18.25%	322,110 $776,000
Q1 2025 May 15, 2025	SELL	$2.21 - $6.13 $5.27 Million - $14.6 Million	-2,384,485 Reduced 85.82%	394,012 $870,000
Q4 2024 Feb 13, 2025	BUY	$4.42 - $8.5 $12.2 Million - $23.5 Million	2,763,072 Added 17912.95%	2,778,497 $15.1 Million
Q3 2024 Nov 14, 2024	SELL	$6.84 - $9.73 $27.3 Million - $38.8 Million	-3,989,459 Reduced 99.61%	15,425 $128,000
Q2 2024 Aug 14, 2024	SELL	$6.87 - $11.34 $5.67 Million - $9.35 Million	-824,862 Reduced 17.08%	4,004,884 $28.7 Million
Q1 2024 May 15, 2024	BUY	$5.11 - $8.76 $11.2 Million - $19.1 Million	2,182,413 Added 82.44%	4,829,746 $41.9 Million
Q4 2023 Feb 14, 2024	BUY	$4.7 - $9.87 $8.88 Million - $18.7 Million	1,889,796 Added 249.47%	2,647,333 $17.3 Million
Q3 2023 Nov 14, 2023	BUY	$9.14 - $12.85 $6.43 Million - $9.04 Million	703,612 Added 1304.8%	757,537 $7.58 Million
Q2 2023 Aug 14, 2023	SELL	$12.09 - $15.0 $20.5 Million - $25.5 Million	-1,699,014 Reduced 96.92%	53,925 $670,000
Q1 2023 May 15, 2023	SELL	$12.99 - $16.48 $12.8 Million - $16.3 Million	-987,757 Reduced 36.04%	1,752,939 $24.6 Million
Q4 2022 Feb 14, 2023	BUY	$12.5 - $24.78 $8.3 Million - $16.4 Million	663,660 Added 31.95%	2,740,696 $39.2 Million
Q3 2022 Nov 14, 2022	BUY	$20.6 - $30.37 $31.7 Million - $46.7 Million	1,538,680 Added 285.81%	2,077,036 $53 Million
Q2 2022 Aug 15, 2022	BUY	$26.05 - $37.48 $967,601 - $1.39 Million	37,144 Added 7.41%	538,356 $15.3 Million
Q1 2022 May 16, 2022	BUY	$24.46 - $40.92 $2.6 Million - $4.35 Million	106,404 Added 26.95%	501,212 $17.7 Million
Q4 2021 Feb 14, 2022	SELL	$35.0 - $45.94 $38.3 Million - $50.2 Million	-1,093,208 Reduced 73.47%	394,808 $16.5 Million
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $52 Million - $85.7 Million	1,414,052 Added 1911.81%	1,488,016 $73 Million
Q2 2021 Aug 13, 2021	SELL	$32.46 - $45.0 $5.3 Million - $7.34 Million	-163,221 Reduced 68.82%	73,964 $3.09 Million
Q1 2021 May 17, 2021	SELL	$25.8 - $38.49 $3.25 Million - $4.84 Million	-125,795 Reduced 34.66%	237,185 $8.45 Million
Q4 2020 Feb 16, 2021	BUY	$24.5 - $30.86 $8.89 Million - $11.2 Million	362,980 New	362,980 $10.2 Million

Others Institutions Holding MRVI

# of Institutions

174

Shares Held

130M

Call Options Held

426K

Put Options Held

37.5K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $354M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Maravai Lifesciences Holdings, Inc. Transaction History